FS-C57BL Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Mouse cell lines |
| Organism |
Mouse |
| Donor History |
Sarcoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: RPMI 1640 ,w: 2.0 mM stable Glutamine ,w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1 x 10⁴ cells/cm² will yield in a confluent layer in about 2to3 days. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
FS-C57BL is a fibrosarcoma cell line derived from C57BL mice, commonly utilized in cancer research. The origin of this cell line traces back to spontaneous tumor formations in these mice, which are genetically modified to be predisposed to cancer. The FS-C57BL cell line is significant for its robust growth and reproducibility in experimental settings, making it a valuable tool for studying cancer biology, especially in the context of fibrosarcoma. The cell line exhibits characteristics typical of sarcomas, including high mitotic index and the ability to form tumors when inoculated into compatible hosts.
In research, FS-C57BL is often used to explore the cellular mechanisms underlying fibrosarcoma progression and metastasis. It serves as a model to assess the efficacy of chemotherapeutic agents and to study the genetic and molecular pathways involved in tumor growth and response to treatment. Researchers also leverage this cell line to investigate immune responses in cancer, benefiting from the C57BL mouse’s well-documented immune profile. Thus, FS-C57BL aids in bridging in vitro experiments with in vivo outcomes, enhancing the translational relevance of the research conducted with these cells.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

